3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
20
OTHER_GOV
1
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Esophageal Neoplasms
3
Breast Neoplasms
3
Recurrence
2
Fallopian Tube Neoplasms
2
Uterine Cervical Neoplasms
1
Unresectable Non-small Cell Lung Cancer
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Sexual Dysfunction, Physiological
1
Radiation Injuries
1
Prostatic Neoplasms
1
Pilonidal Sinus
1
Pain, Postoperative
1
Pain
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Intestinal Diseases
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Death
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Adenocarcinoma
1
Interventions
Irinotecan
6
S 1 (combination)
4
Oxaliplatin
3
palbociclib
2
durvalumab
2
Tamoxifen
2
Radiation
2
Erlotinib Hydrochloride
2
Cetuximab
2
Capecitabine
2
tremelimumab
1
trametinib
1
titanium silicide
1
sintilimab
1
olaparib
1
nilotinib
1
glasdegib
1
genexol-PM
1
futibatinib
1
dabrafenib
1
ceritinib
1
capmatinib
1
anlotinib
1
Temozolomide
1
Talc
1
Surgical Procedures, Operative
1
Radiosurgery
1
Pancreatectomy
1
Paclitaxel
1
Methylene Blue
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Neoplasm Metastasis
×
Surgical Procedures, Operative
×
Clear all
NCT06363591
2025-03-05
WoW
Vastra Gotaland Region
Phase NA
Recruiting
2,486 enrolled